GO:0090288 negative regulation of cellular response to growth factor stimulus: Signaling Brake, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090288 describes any process that decreases the rate, frequency, or extent of a cell's response to a growth factor stimulus.
• It is a biological_process term that acts as a signaling brake, preventing excessive or prolonged growth factor signaling.
• Key molecular players include NF-kappaB pathway components such as IkappaB proteins that sequester growth factor-induced transcription factors.
• Dysregulation of this negative feedback loop is implicated in cancer, neuromuscular disorders, and metabolic diseases [2,6,7].
• CRISPR knockout, point mutation, and knock-in models are essential to dissect causal roles of negative regulators in growth factor signaling [2,5].
• Understanding this process aids in identifying therapeutic targets for diseases driven by aberrant growth factor responses [4,8].
Description
The Gene Ontology (GO) term GO:0090288, negative regulation of cellular response to growth factor stimulus, defines any process that decreases the rate, frequency, or extent of a cellular change in state or activity (e.g., movement, secretion, enzyme production, gene expression) triggered by a growth factor. Growth factors are critical for normal development and tissue homeostasis, but their signals must be tightly controlled to avoid pathological outcomes. This term captures the diverse mechanisms cells use to dampen growth factor signaling, ensuring appropriate responses. Researchers study this process to understand how cells maintain signaling balance and how its disruption contributes to diseases such as cancer and neuromuscular disorders [2,6,7]. The negative regulation can occur at multiple levels, including receptor downregulation, sequestration of signaling intermediates, and induction of feedback inhibitors. This article explores the definition, mechanisms, key genes, and research methods for studying GO:0090288, with a focus on CRISPR-based models and bioinformatics.
negative regulation of cellular response to growth factor stimulus At A Glance
| GO ID | GO:0090288 |
|---|---|
| GO term | negative regulation of cellular response to growth factor stimulus |
| Ontology | biological_process |
| Synonym | none |
| Major function | Dampening cellular responses to growth factors to maintain signaling homeostasis |
| Related processes | Negative regulation of signal transduction; regulation of cell proliferation; feedback inhibition of growth factor pathways |
| Key regulators | IkappaB proteins, phosphatases, ubiquitin ligases, microRNAs |
| Disease relevance | Cancer, neuromuscular disorders, metabolic diseases, inflammatory conditions |
What Is GO:0090288?
GO:0090288 is a biological process that encompasses any mechanism that reduces the magnitude or duration of a cell's response to a growth factor stimulus. According to the QuickGO definition, it includes processes that decrease the rate, frequency, or extent of changes in cell state or activity—such as movement, secretion, enzyme production, or gene expression—that occur as a result of growth factor stimulation. This term is distinct from positive regulation and is essential for preventing excessive signaling that could lead to uncontrolled cell proliferation or differentiation.
Why Is negative regulation of cellular response to growth factor stimulus Important in Cell Biology?
Negative regulation of cellular response to growth factor stimulus is crucial for normal development and tissue homeostasis. Without proper brakes, growth factor signaling can become hyperactive, driving uncontrolled cell proliferation, migration, and survival, which are hallmarks of cancer [1,6,7]. This process also plays a role in limiting inflammatory responses and preventing fibrosis. In neuromuscular disorders, dysfunctional negative regulation can contribute to satellite cell dysfunction and impaired muscle regeneration. Understanding the molecular players and mechanisms of this process is therefore essential for developing targeted therapies for a wide range of diseases.
• Prevents excessive growth factor signaling that can lead to tumorigenesis [1,6].
• Maintains tissue homeostasis by balancing cell proliferation and differentiation.
• Limits inflammatory responses driven by growth factors such as TGF-beta.
• Plays a role in muscle regeneration and neuromuscular disorders.
• Influences metabolic processes, including those related to hypoxia and exercise.
• Regulates cell cycle progression and apoptosis.
• Dysregulation is linked to papillary thyroid cancer and lung adenocarcinoma [6,7].
• Provides targets for therapeutic intervention in cancer and fibrosis.
• Essential for proper immune cell function and cytokine production.
• Impacts stem cell quiescence and activation.
What Happens During negative regulation of cellular response to growth factor stimulus?
Receptor Downregulation and Desensitization
In simple terms: Cells reduce the number of growth factor receptors on their surface or make them less sensitive.
Upon prolonged growth factor stimulation, cells can internalize and degrade receptors or modify them to reduce signaling. This process involves ubiquitination and endocytosis, leading to decreased receptor availability. For example, negative regulation of growth factor signaling often involves the induction of feedback inhibitors that target receptors for degradation.
Sequestration of Signaling Intermediates
In simple terms: Proteins that would normally carry the growth factor signal are held back or trapped.
Inhibitory proteins such as IkappaB bind to and sequester transcription factors like NF-kappaB in the cytoplasm, preventing them from entering the nucleus and activating growth factor-responsive genes. This mechanism is a key example of negative regulation, as described in the IkappaB-NF-kappaB signaling module.
Induction of Feedback Inhibitors
In simple terms: The growth factor signal itself turns on genes that shut down the signal.
Growth factor stimulation can induce the expression of negative regulators, such as phosphatases (e.g., MKP-1) or SOCS proteins, which attenuate the signaling cascade. This negative feedback loop ensures that the response is transient and self-limiting.
Epigenetic and Transcriptional Repression
In simple terms: Cells can lock away genes needed for growth factor responses, making them harder to activate.
Negative regulation can occur through chromatin modifications and transcriptional repressors that reduce the expression of growth factor receptors or downstream effectors. This long-term silencing helps maintain cellular quiescence and prevent aberrant activation.
MicroRNA-Mediated Silencing
In simple terms: Small RNA molecules block the production of proteins involved in growth factor signaling.
MicroRNAs such as miR-940 can target mRNAs encoding growth factor pathway components, leading to their degradation or translational repression. Decreased expression of such microRNAs has been associated with negative prognosis in lung adenocarcinoma, highlighting the importance of this layer of regulation.
Key Genes Involved in GO:0090288 negative regulation of cellular response to growth factor stimulus
The following genes and proteins are key players in the negative regulation of cellular response to growth factor stimulus, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NFKBIA (IkappaB-alpha) | Sequesters NF-kappaB in cytoplasm, preventing growth factor-induced gene expression | Central to temporal control of NF-kappaB signaling |
| NFKBIB (IkappaB-beta) | Inhibits NF-kappaB DNA binding, contributing to negative feedback | Modulates duration of growth factor responses |
| NFKBIE (IkappaB-epsilon) | Regulates NF-kappaB activity in response to growth factors | Involved in immune and inflammatory signaling |
| DUSP1 (MKP-1) | Phosphatase that inactivates MAP kinases downstream of growth factor receptors | Attenuates proliferative signaling |
| SOCS1 | Suppresses cytokine and growth factor receptor signaling via ubiquitination | Negative regulator of JAK/STAT pathway |
| SOCS3 | Inhibits JAK/STAT signaling induced by growth factors | Linked to inflammation and cancer |
| MIR940 | MicroRNA that targets growth factor pathway mRNAs | Decreased expression predicts negative prognosis in lung adenocarcinoma |
| HIF1A | Transcription factor regulated by oxygen; involved in exercise-induced muscle adaptation | Skeletal muscle hypoxia-inducible factor-1 and exercise |
| MIR21 | OncomiR that can modulate growth factor signaling | Implicated in papillary thyroid cancer |
| MIR146A | Negative regulator of NF-kappaB signaling | Involved in inflammatory responses |
| MIR155 | Modulates growth factor receptor signaling | Associated with immune regulation |
| TGFBR3 | Betaglycan, a co-receptor that can sequester TGF-beta | Negative regulation of TGF-beta signaling |
| SMAD7 | Inhibitory SMAD that blocks TGF-beta receptor signaling | Negative feedback in TGF-beta pathway |
| PTEN | Lipid phosphatase that antagonizes PI3K/AKT growth factor signaling | Tumor suppressor |
| CBL | E3 ubiquitin ligase that targets growth factor receptors for degradation | Negative regulator of receptor tyrosine kinases |
| ERRFI1 (MIG6) | Feedback inhibitor of EGFR signaling | Attenuates EGF-induced proliferation |
| SPRY2 | Inhibits RTK signaling by interfering with GRB2-SOS complex | Negative regulator of FGF signaling |
| RGS proteins | Regulate G-protein coupled receptor signaling induced by growth factors | Modulate diverse growth factor responses |
How Is negative regulation of cellular response to growth factor stimulus Regulated?
The negative regulation of cellular response to growth factor stimulus is itself tightly regulated. Key mechanisms include the IkappaB-NF-kappaB signaling module, which controls the temporal dynamics of NF-kappaB activation and ensures transient responses to growth factors. Additionally, hypoxia-inducible factor-1 (HIF-1) regulates genes involved in muscle adaptation to exercise, which can include negative feedback components. MicroRNAs such as miR-940 and miR-21 fine-tune the expression of growth factor pathway components, adding another layer of regulation [6,7]. Inflammatory diets can modulate these pathways, affecting the balance between positive and negative regulation. Overall, this process is controlled by a complex network of feedback loops, post-translational modifications, and transcriptional programs.
negative regulation of cellular response to growth factor stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Cancer (multiple types) | Knockout in cancer cell lines; point mutation to assess phosphatase activity |
| SMAD7 | Fibrosis, cancer | Overexpression in fibroblasts; knockout in epithelial cells |
| MIR940 | Lung adenocarcinoma | Knock-in of miR-940 in lung cancer cells; knockout in normal lung cells |
| NFKBIA | Inflammatory diseases, cancer | Point mutation to prevent IkappaB phosphorylation; knockout in macrophages |
| HIF1A | Muscle metabolism, exercise adaptation | Knockout in skeletal muscle cells; knock-in of hypoxia-resistant mutant |
Cancer
Dysregulation of negative regulation of growth factor signaling is a hallmark of cancer. Loss of negative regulators such as PTEN or SMAD7 leads to hyperactive growth factor pathways, promoting uncontrolled proliferation and survival. In papillary thyroid cancer, microRNA profiling has revealed alterations in negative regulators that may contribute to tumorigenesis. Similarly, decreased expression of miR-940, a negative regulator, predicts poor prognosis in early-stage lung adenocarcinoma.
Neuromuscular Disorders
Muscle satellite cell dysfunction is a key feature of neuromuscular disorders. Impaired negative regulation of growth factor signaling can lead to aberrant satellite cell activation and exhaustion, contributing to muscle degeneration. Understanding these mechanisms may reveal therapeutic targets for conditions such as muscular dystrophy.
Inflammatory and Metabolic Diseases
Chronic inflammation and metabolic disorders often involve sustained growth factor signaling. Anti-inflammatory diets may modulate negative regulatory pathways, reducing the risk of diseases driven by excessive growth factor responses. Hypoxia-inducible factor-1 (HIF-1) regulation in skeletal muscle during exercise highlights the intersection of metabolic stress and growth factor signaling.
From negative regulation of cellular response to growth factor stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a negative regulator enhance growth factor signaling? | CRISPR knockout of the candidate gene in relevant cell type |
| Does a specific phosphorylation site on a negative regulator control its function? | Point mutation (e.g., phospho-deficient or phospho-mimetic) via CRISPR knock-in |
| Does overexpression of a negative regulator suppress tumor growth? | CRISPR-mediated overexpression (e.g., CRISPRa) or lentiviral overexpression |
| How does a disease-associated mutation affect negative regulation? | Knock-in of the patient mutation using CRISPR |
| What is the temporal dynamics of negative feedback? | Tagged knock-in of the regulator with a degron or fluorescent tag |
| Which genes are synthetic lethal with loss of a negative regulator? | CRISPR library screening in knockout background |
How to Study the negative regulation of cellular response to growth factor stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes | Identify negative feedback genes after growth factor stimulation |
| Proteomics | Protein abundance and modifications | Quantify signaling intermediates and feedback regulators |
| Phosphoproteomics | Phosphorylation events | Map kinase cascade attenuation |
| Live-cell imaging | Protein localization and dynamics | Visualize IkappaB-NF-kappaB shuttling |
| CRISPR knockout screens | Gene function loss | Discover novel negative regulators |
| CRISPR activation screens | Gene overexpression | Identify suppressors of growth factor signaling |
| MicroRNA profiling | miRNA expression | Link miRNAs to negative regulation in cancer |
| ChIP-seq | Transcription factor binding | Map NF-kappaB binding at target genes |
Transcriptomics and RNA-seq
RNA sequencing can quantify changes in gene expression following growth factor stimulation and identify negative feedback genes. For example, microRNA profiling in papillary thyroid cancer has revealed altered expression of negative regulators. RNA-seq after CRISPR knockout of a candidate negative regulator can uncover downstream targets and pathways.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can measure protein abundance and phosphorylation changes in growth factor signaling pathways. This is useful to assess the impact of negative regulators on signaling kinetics. For instance, the IkappaB-NF-kappaB module was dissected using quantitative proteomics.
Imaging and Live-Cell Analysis
Fluorescence microscopy with tagged proteins can visualize the localization and dynamics of negative regulators. For example, GFP-tagged IkappaB can show nuclear-cytoplasmic shuttling in response to growth factors. Live-cell imaging of CRISPR knock-in cell lines enables real-time monitoring of signaling.
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify novel negative regulators of growth factor signaling. These screens are powerful for discovering genes that, when lost, hypersensitize cells to growth factors. Such approaches have been used to study muscle satellite cell dysfunction.
How CRISPR Can Be Used to Study GO:0090288 negative regulation of cellular response to growth factor stimulus
Knockout
CRISPR knockout of negative regulator genes (e.g., NFKBIA, PTEN, SMAD7) can be used to assess their role in dampening growth factor signaling. Loss of function typically leads to enhanced and prolonged responses, which can be measured by reporter assays or RNA-seq. Knockout models are essential for validating causal roles in disease [2,5].
Point Mutation
Point mutations can be introduced to study specific residues critical for negative regulator function, such as phosphorylation sites on IkappaB or catalytic residues in phosphatases. CRISPR-mediated point mutation allows precise interrogation of molecular mechanisms without altering protein levels.
Knock-in
Knock-in of tagged versions (e.g., GFP, HA, degron) of negative regulators enables real-time tracking and controlled degradation. Additionally, knock-in of disease-associated mutations can model their impact on negative regulation. This approach is valuable for studying temporal dynamics.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can be used to increase levels of negative regulators, testing whether this suppresses growth factor signaling and related phenotypes such as proliferation. Overexpression models are useful for gain-of-function studies and therapeutic target validation.
How EDITGENE Supports negative regulation of cellular response to growth factor stimulus Research
Researchers studying negative regulation of cellular response to growth factor stimulus-related genes often need to determine whether a candidate gene is causally involved in dampening signaling, and how mutations affect this function. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of cellular response to growth factor stimulus research.
Frequently Asked Questions About negative regulation of cellular response to growth factor stimulus
What is GO:0090288?
GO:0090288 is a Gene Ontology term for negative regulation of cellular response to growth factor stimulus, describing any process that decreases the rate, frequency, or extent of a cell's response to growth factors.
What genes are involved in negative regulation of cellular response to growth factor stimulus?
Key genes include NFKBIA, NFKBIB, PTEN, SMAD7, SOCS1, SOCS3, DUSP1, and microRNAs such as miR-940 and miR-21 [1,6,7].
How does negative regulation of growth factor signaling prevent cancer?
By dampening excessive proliferative signals, negative regulators like PTEN and SMAD7 prevent uncontrolled cell growth; their loss is associated with cancer [1,6,7].
What diseases are linked to defects in negative regulation of growth factor signaling?
Cancer, neuromuscular disorders, inflammatory diseases, and metabolic disorders have been linked to dysregulation of this process [2,4,6,7].
What experimental models are used to study negative regulation of growth factor signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models in cell lines and animal models are commonly used [2,5].
How can CRISPR be used to study negative regulators?
CRISPR can create knockout, point mutation, knock-in, or overexpression of candidate genes to assess their impact on growth factor signaling [1,2].
What is the role of NF-kappaB in negative regulation of growth factor signaling?
NF-kappaB is a transcription factor that is sequestered by IkappaB proteins, which act as negative regulators to prevent excessive growth factor-induced gene expression.
How do microRNAs contribute to negative regulation of growth factor signaling?
MicroRNAs such as miR-940 can target mRNAs of growth factor pathway components, reducing their expression and dampening signaling.
What methods are used to measure negative regulation of growth factor signaling?
RNA-seq, proteomics, phosphoproteomics, live-cell imaging, and CRISPR screens are commonly used [1,7].
Why is negative regulation of growth factor signaling important in muscle?
It regulates satellite cell function and muscle regeneration; dysfunction contributes to neuromuscular disorders.
Conclusion
GO:0090288, negative regulation of cellular response to growth factor stimulus, is a critical biological process that maintains signaling homeostasis and prevents disease. Its mechanisms involve a complex network of inhibitors, feedback loops, and microRNAs. Understanding these processes is essential for developing therapies for cancer, neuromuscular disorders, and inflammatory diseases. CRISPR-based models and advanced bioinformatics are powerful tools to dissect these pathways, and EDITGENE offers comprehensive services to support such research.
References
- 1. Hoffmann A et al.. 2002. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.. Science 298(5596):1241-5 PMID: 12424381
- 2. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 4. Scheiber A et al.. 2026. Anti-Inflammatory Diets.. PMID: 37983365
- 5. Yan T et al.. 2024. Age-related mitophagy regulates orthodontic tooth movement by affecting PDLSCs mitochondrial function and RANKL/OPG.. FASEB J 38(15):e23865 PMID: 39096136
- 6. Ma Q et al.. 2021. Decreased miR-940 expression can predict a negative prognosis in early-stage nonsmoking female lung adenocarcinoma.. Transl Lung Cancer Res 10(11):4293-4302 PMID: 35004257
- 7. Armos R et al.. 2024. MicroRNA Profiling in Papillary Thyroid Cancer.. Int J Mol Sci 25(17) PMID: 39273308
- 8. Lindholm ME et al.. 2016. Skeletal muscle hypoxia-inducible factor-1 and exercise.. Exp Physiol 101(1):28-32 PMID: 26391197
